Michael T. Rudd

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 254 citations · Full text

Structural basis for selectivity and diversity in angiotensin II receptors

Haitao Zhang, Gye Won Han, A. Batyuk et al. · Nature · 2017 · 212 citations · Full text

Molecular Physiology, Signal Transduction, G Protein-coupled Receptor +9

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Steven J. Harper, John A. McCauley, Michael T. Rudd et al. · ACS Medicinal Chemistry Letters · 2012 · 201 citations · Full text

Immunology, Molecular Biology, Pharmacotherapy +19

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

John A. McCauley, Charles McIntyre, Michael T. Rudd et al. · Journal of Medicinal Chemistry · 2010 · 176 citations

Immunology, Antiviral Drug, Medicinal Chemistry +17

MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease

Nigel J. Liverton, Steven S. Carroll, Jillian DiMuzio et al. · Antimicrobial Agents and Chemotherapy · 2009 · 141 citations · Full text

Immunology, Molecular Biology, Antiviral Drug +17